National

Supply order for Covishield vaccine was placed after drug regulator approved it: Govt

For the procurement of COVID-19 vaccines, a supply order dated January 11 was placed with the Serum Institute of India after Covishield was approved for restricted use in emergency situation by India's drug regulator, the Rajya Sabha was informed on Tuesday.

migrator

Updated:2nd Feb, 2021 at 2:27 PM

New Delhi

Union Minister of State for Health Ashwini Choubey was responding to a question on whether the government has finalised a pricing and supply agreement with the Serum Institute of India Limited for COVID-19 vaccines.

Covishield is being manufactured by the Pune-based firm with technology transfer from AstraZeneca/Oxford University.

On whether it is a fact that multiple doses of the vaccine produced for India could not be rolled out despite approval due to the lack of a formal agreement for supply, Choubey, in a written reply, said, '' No. As per protocol, the supply order for COVID-19 vaccines, specifying the number of vaccine doses, was placed with the manufacturer and vaccines were delivered within 3 days to the states and UTs and other consignee points.''

Supply order for Covishield vaccine was placed after drug regulator approved it: Govt

For the procurement of COVID-19 vaccines, a supply order dated January 11 was placed with the Serum Institute of India after Covishield was approved for restricted use in emergency situation by India's drug regulator, the Rajya Sabha was informed on Tuesday.

Also Read

TNCRW demands accountability for frisking students for CM Vijay's school visit

TNPDCL proposes Rs 0.63/unit surcharge on open access consumers

IIT Madras-led deep-tech fund achieves Rs 450 Cr first close

Left backs bank strike, urges Centre to hold talks

Saishiva, Bhuvan remain unbeaten in MRF National Racing Challenge